EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC 4.0

Succinate Dehydrogenase Defects Giant Renal Cell Carcinoma

Xia Sun, Guang Wang, Ziye Huang, Pei Li, Bowei Yang, Tianyun Wang, Jiongming Li

Urologia Internationalis · 2023

DOI: 10.1159/000531059 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Urologia Internationalis, 2023. Verfasst von Xia Sun und 6 weiteren Autor:innen. Beteiligte Einrichtung: The Department of Urology, The Second Affiliated Hospital of Kunming Medical University, Kunming, China. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Succinate dehydrogenase (SDH)-deficient renal cell carcinoma (RCC) is a new subtype of RCC included in the 2016 edition of the WHO classification in RCC. SDH-defective RCC accounts for 0.05–0.2%, and preoperative diagnosis is difficult. We report a severe adherent RCC of inferior vena cava that underwent open radical nephrectomy after preoperative renal artery embolization. Postoperative histopathological examination diagnosed SDH-defective RCC; the clinicopathological stage was pT2b. After 10 months of follow-up, the patient had no evidence of disease recurrence. For patients with large RCC, interventional embolization can be selected to reduce intraoperative bleeding and blood transfusion, and it is recommended to complete interventional surgery within 3–4 h before surgery. SDH-deficient RCC is difficult to distinguish from other renal tumors in imaging, so immunohistochemical examination of SDHB is recommended for young and middle-aged patients, especially those under 45.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellKidney NeoplasmsMiddle AgedHumansSuccinate DehydrogenaseNeoplasm Recurrence, LocalKidneyNephrectomyVena Cava, Inferior

Stichwörter der Autor:innen

Renal artery embolizationRenal cell carcinomaSuccinate dehydrogenase

Substanzen

Succinate Dehydrogenase

Autor:innen und Institutionen

  • The Department of Urology, The Second Affiliated Hospital of Kunming Medical University, Kunming, China.
  • The Department of Urology, The Second Affiliated Hospital of Kunming Medical University, Kunming, China, 438272075@qq.com.
  • The Department of Pathology, The Second Affiliated Hospital of Kunming Medical University, Kunming, China.

Zitieren

APA

Sun, X., Wang, G., Huang, Z., Li, P., Yang, B., Wang, T., & Li, J. (2023). Succinate Dehydrogenase Defects Giant Renal Cell Carcinoma. Urologia Internationalis. https://doi.org/10.1159/000531059

Vancouver

Sun X, Wang G, Huang Z, Li P, Yang B, Wang T, et al. Succinate Dehydrogenase Defects Giant Renal Cell Carcinoma. Urologia Internationalis. 2023. doi:10.1159/000531059

BibTeX
@article{Sun2023,
  author = {Sun, Xia and Wang, Guang and Huang, Ziye and Li, Pei and Yang, Bowei and Wang, Tianyun and Li, Jiongming},
  title = {Succinate Dehydrogenase Defects Giant Renal Cell Carcinoma},
  journal = {Urologia Internationalis},
  year = {2023},
  doi = {10.1159/000531059}
}
Kostenlos starten →